Canagliflozin D4 is the tetra-deuterated form of Canagliflozin (TA-7284; JNJ-24831754ZAE; JNJ 28431754-AAA; JNJ-28431754; Invokana) which is a selective SGLT2 inhibitor approved by FDA for the treatment of type 2 diabetes.

纯度：≥98%

CAS：1997338-61-0